Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bavarian Nordic, Cantargia, Edgewise, Enliven, Forma, Imara, Novo Nordisk.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D-Pharma, Agenus, Albireo, Biocorrx, Biontech, Cassava, Compass, Crinetics, Inotrem, Inovio, Novavax, Ocugen, Otonomy, Pfizer, Relmada, Sifi, Siga, Smart Immune, Vectivbio.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aim, Biomind, Eagle, Elevar, Galectin, Merck & Co., Moerna, Pfizer, Regeneron, Sisaf.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Amolyt, Atai, Avidity, Beigene, Cognition, Corcept, Eupraxia, Evgen, Evofem, Frequency, Fulcrum, Genentech, Janux, Junshi, Kinnate, Leap, Novavax, Sangamo.

It was a busy day at Moderna Inc. as Merck & Co. Inc. exercised its option to jointly develop and commercialize a personalized cancer vaccine with Moderna in a deal the two companies inked in 2016. Moderna also notched another emergency use authorization (EUA) for its COVID-19 vaccine, this one targeting the omicron variant, for use by those under age 18.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aadi, Agenus, Allomek, CLS, Emergex, Immunoprecise, Ligand, Mendus, Mirati, Mirum, Nervgen, Omega, Omniab, Oncotelic, Pasithea, Renbio, Synthetic, Talem, Toregem, VBI, Viewpoint Molecular, Wuxi, Xentic, Zosano.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Everest, GSK, HDT, Innovent, Nanoscope, Novelmed, Pfizer, Scpharmaceuticals, Supernus.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Brooklyn, Cara, Christianacare, Cocrystal, Corrixr, Compass, Eli Lilly, Enteris, Eterna, ICER, Karuna, Merck and Co., Muna, Nimbus, Psychogenics, SWK and Synergys.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinogen, Ascletis, Brainstorm, G1, Hutchmed, Immatics, Iovance, Janssen, Merck KGaA, Morphic, Sciwind, Tenax.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Diurnal, Hugel, Knight, Lyell, Revive.